Skip to main content

CEO says Hormel Foods is well-positioned as weight-loss drugs grow popular

Hormel Foods CEO Jim Snee told CNBC's Jim Cramer his company's varied "protein portfolio" is advantageous as weight-loss drugs gain popularity.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.